June 20, 2025

Establishing Novel Models of Interdisciplinary Care to Improve Survival Outcomes in Patients With Cancer

Internationally renowned for her decades-long pioneering research in pancreatic cancer, in 2024, Diane M. Simeone, MD, left her positions as the Laura and Isaac Perlmutter Professor of Surgery and Pat...

The ASCO Post

June 20, 2025

Outcomes of Oncologic Extended Resection for Gallbladder Cancer: Results of a Global Analysis

An analysis of medical records across seven countries aimed to examine outcomes of resection among patients with T3 and T4 gallbladder cancer.

The ASCO Post

June 20, 2025

Retinal Changes Linked to Neurological Disease Progression

New research reviewed dozens of studies and revealed that visual dysfunction, including retinal changes, may serve as early signs of neurodegenerative and neurodevelopmental diseases, offering a noninvasive pathway for earlier diagnosis and disease monitoring.

Conexiant

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant

June 17, 2025

High Recurrence Seen in Epithelioid Phyllodes Tumors

Researchers describe epithelioid phyllodes tumors as a potential distinct subtype of breast tumor, marked by unique morphological characteristics

The Pathologist

June 16, 2025

Revisiting Margin Width Guidelines for Ductal Carcinoma In Situ and the Role of Routine Reexcision

For postmenopausal women with HR-positive ductal carcinoma in situ (DCIS) treated with breast-conserving surgery, whole-breast irradiation, and adjuvant endocrine therapy, reexcision to achieve wider ...

The ASCO Post

June 16, 2025

Cohort Study Shows Benefits of Bilateral Salpingo-Oophorectomy Without Increased Health Risks

Patients with a history of breast cancer who are carriers of BRCA1 and BRCA2 pathogenic variants benefit from undergoing bilateral salpingo-oophorectomy, the results of a retrospective cohort study pu...

The ASCO Post

June 16, 2025

Therapy With a Tyrosine Kinase Inhibitor for EGFR-Variant Lung Adenocarcinoma: Lessons From Chronic Myeloid Leukemia?

Unresolved issues persist in treating EGFR-variant lung adenocarcinoma with tyrosine kinase inhibitors, contrasting with chronic myeloid leukemia (CML) therapy. Comparisons reveal complexities and uncertainties in patient selection, therapy monitoring, and treatment duration.

The ASCO Post

June 16, 2025

Breast Cancer Radiotherapy: 1- vs 3-Week Course

Researchers have examined the safety and efficacy of a 1-week course of postsurgery radiotherapy compared with a traditional 3-week regimen in patients with early-stage breast cancer, according to fin...

The ASCO Post